What is usually the first manifestation of multiple endocrine neoplasia MEN 2a and 2b?
Thyroid Gland Medullar thyroid cancer (MTC) is the most common manifestation of MEN2A and MEN2B with 100% penetrance and usually the first manifestation in MEN2 patients.
What is the MEN2 gene?
MEN2 syndrome is caused by a mutation (change) in a gene called RET, and is divided into three subtypes (MEN2A, MEN2B, and FMTC). People with all subtypes of MEN2 syndrome have an increased risk of medullary thyroid cancer, pheochromocytoma, and parathyroid gland cancer.
What is MEN2 syndrome?
Multiple endocrine neoplasia type 2 (MEN2) is a hereditary condition associated with 3 primary types of tumors: medullary thyroid cancer, parathyroid tumors, and pheochromocytoma. MEN2 is classified into subtypes based on clinical features. MEN2A, which affects 95% of MEN2 families.
How do you test for MEN2?
What are the screening options for MEN2?
- Yearly blood tests for ionized calcium and parathyroid hormone levels, beginning in childhood (for people with MEN2A)
- Yearly blood tests for catecholamines and catecholamine metabolites (metanephrine and normetanephrine), beginning in childhood (for people with MEN2A and MEN2B)
What does RET gene do?
The RET gene provides instructions for producing a protein that is involved in signaling within cells.
What is the function of the RET gene?
What does RET mutation mean?
If you have a mutation in the RET gene, this means you have a condition called Multiple Endocrine Neoplasia type 2 (MEN 2). MEN 2 increases your risk for certain types of cancers, including medullary thyroid cancer (a specific type of thyroid cancer).
What is a RET mutation?
Where is the RET gene located?
chromosome 10
RET is an abbreviation for “rearranged during transfection”, as the DNA sequence of this gene was originally found to be rearranged within a 3T3 fibroblast cell line following its transfection with DNA taken from human lymphoma cells. The human gene RET is localized to chromosome 10 (10q11.